Stay updated on Early Ixekizumab Activity in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.

Latest updates to the Early Ixekizumab Activity in Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes regarding a study on psoriasis, with the removal of detailed inclusion and exclusion criteria and the revision number updated from v2.14.4 to v2.15.0.SummaryDifference11%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Early Ixekizumab Activity in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.